Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hung, K.-Y.
Right arrow Articles by Tsai, T.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hung, K.-Y.
Right arrow Articles by Tsai, T.-J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 670-676
© 2003 European Renal Association-European Dialysis and Transplant Association

Pentoxifylline modulates intracellular signalling of TGF-ß in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosis

Kuan-Yu Hung1,2, Jenq-Wen Huang2, Chin-Tin Chen3,, Po-Huang Lee4 and Tun-Jun Tsai2

1 Department of Internal Medicine, Far-Eastern Memorial Hospital, Pan-Chiao, 2 Department of Internal Medicine, 3 Center for Optoelectronic Biomedicine and 4 Department of Surgery, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC

Background. Peritoneal matrix accumulation is a major characteristic of encapsulating peritoneal sclerosis (EPS), which is a serious complication in long-term peritoneal dialysis (PD) patients. We reported previously that TGF-ß stimulates collagen gene expression in cultured HPMC, and is attenuated by pentoxifylline (PTX). The SMAD family and the mitogen-activated protein kinase (MAPK) (ERK1/2, JNK and p38HOG) pathways have been shown to participate in TGF-ß signalling. However, how PTX modulates the intracellular signalling downstream to TGF-ß remains undetermined in HPMC. In this study, we explored these signalling pathways in HPMC, and investigated the molecular mechanisms involved in the inhibitory effects of PTX on TGF-ß-induced collagen gene expression in HPMC.

Methods. HPMC was cultured from human omentum by an enzyme digestion method. The expression of collagen {alpha}1(I) mRNA was determined by northern blotting, while the SMAD proteins and the MAPK kinase activity were determined by western blotting.

Results. TGF-ß-stimulated collagen {alpha}1(I) mRNA expression of HPMC was inhibited by PTX. The Smad2, ERK1/2 and p38HOG pathways were activated in response to TGF-ß. However, TGF-ß displayed no activation of the JNK pathway in HPMC. The addition of PD98059 and SB203580, which blocked the activation of ERK1/2 and p38HOG, respectively, suppressed the TGF-ß-induced collagen {alpha}1(I) mRNA expression. At a concentration (300 µg/ml) that inhibited the collagen gene expression, PTX suppressed the ERK1/2 and p38HOG activation by TGF-ß. In contrast, PTX had no effect on the TGF-ß-induced activation of Smad2, under the same concentration.

Conclusion. PTX inhibits the TGF-ß-induced collagen gene expression in HPMC through modulating the ERK1/2 and p38HOG pathways. Our study of PTX may provide the therapeutic basis for clinical applications in the prevention of EPS.

Keywords: encapsulating peritoneal sclerosis; mesothelial cell; pentoxifylline; signal transduction; TGF-ß

Correspondence and offprint requests to: Chin-Tin Chen, Center for Optoelectronic Biomedicine, National Taiwan University, Medical College, No. 1, Jen-Ai Road, 1st Section, Taipei, Taiwan, ROC. Email: ctchen{at}ha.mc.ntu.edu.tw


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Mizuno, Y. Ito, N. Hepburn, T. Mizuno, Y. Noda, Y. Yuzawa, C. L. Harris, B. P. Morgan, and S. Matsuo
Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis Model
J. Immunol., July 15, 2009; 183(2): 1403 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K.-Y. Hung, J.-W. Huang, C.-K. Chiang, and T.-J. Tsai
Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3831 - 3840.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Guo, J. C.K. Leung, M. F. Lam, L. Y.Y. Chan, A. W.L. Tsang, H. Y. Lan, and K. N. Lai
Smad7 Transgene Attenuates Peritoneal Fibrosis in Uremic Rats Treated with Peritoneal Dialysis
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2689 - 2703.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
K.-Y. Hung, K.-D. Wu, and T.-J. Tsai
IN VITRO STUDY OF PERITONEAL FIBROSIS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S72 - S75.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
K. Kaneko, C. Hamada, and Y. Tomino
PERITONEAL FIBROSIS INTERVENTION
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S82 - S86.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Jofre, P. Rodriguez-Benitez, J. M. Lopez-Gomez, and R. Perez-Garcia
Inflammatory Syndrome in Patients on Hemodialysis
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S274 - S280.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.